Rakesh C. Patel, M.D. 1812 North Mills Avenue Orlando, FL 32803 Education:
Division of Urology, Department of Surgery
Current Position: June 2003-present
University of Florida Urology Research Award, 2002
Licensure:
Book Chapters:
Endourological Management of Ureteral Strictures,
Rakesh C. Patel, M.D. Professional Associations: American Urological Association American College of Surgeons, Resident Candidate Florida Urological Association
Academic Appointments:
Associate Clinical Professor of Surgery-Division of Urology
Presentations:
Perineal Prostatectomy, “How we do it and why”
Department of General Surgery Grand Rounds
Department of General Surgery Grand Rounds
Testicular Cancer – Department of General Surgery Grand Rounds
Research: 2002
Ureteral Strictures in Kidney Transplant Recipients
University of Florida Experience with Laparoscopic Donor Nephrectomies
“A Randomized, Double-Blind, Placebo-Controlled, Parallel Group
Study of the Efficacy and Safety of Study Drug 0.5mg Administered
Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable
“An Open-Label Study to Evaluate the Efficacy and Safety of Study Drug
Administered ‘On Demand’ to Men of Various Populations with Erectile
Rakesh C. Patel, M.D. Research:
“Open-Label Study of the Efficacy and Safety of 5mg and 10mg Study
Drug in Patients with Overactive Bladder Symptoms”
“A Randomized, Double-Blind, Placebo-Controlled, Multicenter
Efficacy and Safety Study of Study Drug for the Prevention of
“REALISE: Real Life Safety and Efficacy on Levitra®”
“A Phase 3, Parallel Group, Randomized, Double-Blind, Placebo
And Safety of Study Drug Sustained Release in Subjects with
“Study of Study Drug in Women of Different Demographic
Co-morbidities with Stress Urinary Incontinence:
“A Study to Compare the Safety and Efficacy of Once Daily Study
Drug Versus Twice Daily Study Drug in the Treatment of Complicated
“A Double-Blind, Randomized, Placebo-Controlled Trial of Elmiron®
For The Treatment of Chronic, Non-Bacterial Prostatitis”
“A Randomized, Double-Blind, Crossover Study to Evaluate the Duration of Erection Following Study Drug 10mg Administration For 4 Weeks in a Fixed-Dose Regimen Compared to Placebo in Males with ED”
“An Open-Label, Multicenter Study to Assess the Efficacy and Safety
of Daily Oral Administration of 5 and 10mg Study Drug in Patients
Who Wish to Switch from Detrol LA for the Treatment of Overactive
“Prospective, Observational Registry and Patient Survey of the Management
Rakesh C. Patel, M.D. Research: 2005-present
Double-Blind, Randomized, Parallel Study
“A Multicenter, 2 Week, Double-Blind Study of XXXX 60mg QD
Morning or In The Evening In Patients With Overactive Bladder”
“A Randomized, Double-Blind, Placebo-Controlled, Multicenter
Efficacy and Safety Study of XXXX for the Prevention of Prostate
Cancer in Men with High Grade Prostate Intraepithelial Neoplasia”
Forme juridique Objectif de gestion Le FCP a pour objectif d’obtenir une performance supérieure à celle de l’indicateur de référence pour optimiser le rendement de contratsd'assurance-vie libellés en unités de compte relevant de l'option dite "DSK". Date de création Catégorie Engine - EuroPerformance Performances * Cumulées Classification AMF